2024 annual financial data
Revelation Biosciences 2024 Operating margin
Revelation Biosciences 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -7,975,109 USD and net income was -15,038,536 USD.
Operating cash flow was -18,321,276 USD.
Get free Revelation Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -7,975,109 USD
- Net income
- -15,038,536 USD
- Operating cash flow
- -18,321,276 USD